COMMUNIQUÉS West-GlobeNewswire

-
Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic's Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer
14/09/2017 - 22:01 -
AB Science annonce que le CHMP a adopté une opinion négative pour l'enregistrement du masitinib dans la mastocytose systémique indolente après réévaluation du dossier
14/09/2017 - 18:47 -
AB Science announces that CHMP adopted a negative opinion for masitinib marketing authorization in indolent systemic mastocytosis after reassessment
14/09/2017 - 18:47 -
Guerbet annonce que Vectorio®, un dispositif médical innovant pour les procédures cTACE, a reçu le marquage CE
14/09/2017 - 18:02 -
Guerbet Announces CE Mark for Vectorio®, An Innovative Medical Device for cTACE Procedures
14/09/2017 - 18:02 -
Nestlé acquires majority interest in Blue Bottle Coffee
14/09/2017 - 18:01 -
Increase of Nexstim Plc's share capital with subscriptions based on stock options 2013A
14/09/2017 - 18:00 -
La plateforme d'oncologie intégrée de CrownBio permet d'anticiper l'immunothérapie HERA GITRL prometteuse d'Apogenix pour le CPNPC et le cancer des voies aérodigestives supérieures
14/09/2017 - 17:25 -
Medtronic Announces Inaugural 2017 Global Champions Team
14/09/2017 - 17:00 -
Targovax Receives 2017 Nordic Stars Award
14/09/2017 - 16:00 -
Bavarian Nordic to Host Capital Markets Day in New York City
14/09/2017 - 14:00 -
Summit Announces Underwritten Public Offering of 1,459,000 ADSs to Raise USD17.5 Million Before Expenses
14/09/2017 - 08:00 -
Terveystalo is planning an initial public offering and a listing on Nasdaq Helsinki Ltd
14/09/2017 - 07:48 -
Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study
14/09/2017 - 07:15 -
ABLYNX ANNOUNCES WARRANT EXERCISE
14/09/2017 - 07:00 -
Bone Therapeutics SA : Reports strong interim results from ALLOB® Phase IIA spinal fusion study
14/09/2017 - 07:00 -
Bone Therapeutics SA : Annonce des résultats intermédiaires robustes dans l'étude de phase IIA avec ALLOB® dans la fusion vertébrale
14/09/2017 - 07:00 -
New Five-Year Gender Subset Data from the Medtronic Engage Registry Presented in VIVA Late Breaking Trials
13/09/2017 - 19:49 -
CROSSJECT : Mise en oeuvre d'un contrat de liquidité
13/09/2017 - 18:37
Pages